Literature DB >> 31377069

Age- and Gender-Specific Prognostic Cutoff Values of Coronary Flow Velocity Reserve in Vasodilator Stress Echocardiography.

Lauro Cortigiani1, Quirino Ciampi2, Alberto Lombardo3, Fausto Rigo4, Francesco Bovenzi5, Eugenio Picano6.   

Abstract

PURPOSE: Coronary flow velocity reserve (CFVR) of the left anterior descending artery is useful for risk stratification during stress echocardiography (SE) as an add-on to regional wall motion abnormalities (RWMA). We sought to provide sex- and age-specific prognostic cutoff values for CFVR.
METHODS: A total of 5,577 patients (2,284 women; 110 age ≥ 85 years) who underwent dipyridamole SE with evaluation of RWMA and CFVR were enrolled in a multicenter prospective SE registry. Death and myocardial infarction were the clinical end points.
RESULTS: During 20 months' median follow-up, 649 events (236 deaths, 413 infarctions) occurred: 288 in women and 38 in patients ≥85 years. At receiver operating characteristics analysis, the best prognostic cutoff value for CFVR was similar for men (2.03) and women (2.02) and consistent across all age strata (<45 years: 2.03; 45-54 years: 2.04; 45-64 years: 2.03; 65-74 and 75-84 years: 2.0) except for patients >85 years, who showed 1.90 as the optimal value. Independent predictors of mortality or myocardial infarction were RWMA (hazard ratio [HR] = 5.42), reduced CFVR (HR = 3.26), resting ejection fraction (HR = 0.98), smoking habit (HR = 1.41), age (HR = 1.02), and prior percutaneous coronary intervention (HR = 1.20) in patients age <85 years; and RWMA (HR = 5.42), smoking habit (HR = 3.24), and resting ejection fraction (HR = 0.97) in those age ≥85 years. CFVR added a prognostic contribution over clinical parameters, resting ejection fraction, and stress-induced RWMA in all age and sex groups except men >85 years.
CONCLUSIONS: A sex-independent value of CFVR ≤2.0 provides the optimal prognostication across all age groups, except for those ≥85 years in whom a cutoff ≤1.90 is needed. Risk stratification is more effective for all age groups when CFVR is combined with RWMA.
Copyright © 2019 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coronary flow; Dipyridamole; Ischemia; Prognosis; Stress echo

Year:  2019        PMID: 31377069     DOI: 10.1016/j.echo.2019.05.020

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  4 in total

1.  Prognostic Value of Transthoracic Doppler Echocardiography Coronary Flow Velocity Reserve in Patients With Asymmetric Hypertrophic Cardiomyopathy.

Authors:  Milorad Tesic; Branko Beleslin; Vojislav Giga; Ivana Jovanovic; Jelena Marinkovic; Danijela Trifunovic; Olga Petrovic; Milan Dobric; Srdjan Aleksandric; Stefan Juricic; Nikola Boskovic; Miloje Tomasevic; Arsen Ristic; Dejan Orlic; Sinisa Stojkovic; Vladan Vukcevic; Goran Stankovic; Miodrag Ostojic; Ana Djordjevic Dikic
Journal:  J Am Heart Assoc       Date:  2021-10-12       Impact factor: 5.501

2.  Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.

Authors:  Mihir A Kelshiker; Henry Seligman; James P Howard; Haseeb Rahman; Michael Foley; Alexandra N Nowbar; Christopher A Rajkumar; Matthew J Shun-Shin; Yousif Ahmad; Sayan Sen; Rasha Al-Lamee; Ricardo Petraco
Journal:  Eur Heart J       Date:  2022-04-19       Impact factor: 35.855

3.  Early effect of percutaneous coronary intervention of non-left anterior descending artery on coronary flow velocity reserve of left anterior descending artery assessed by transthoracic Doppler echocardiography.

Authors:  Masahiro Hada; Masahiro Hoshino; Nobutaka Wakasa; Tomoyo Sugiyama; Yoshihisa Kanaji; Masao Yamaguchi; Toru Misawa; Tatsuhiro Nagamine; Kai Nogami; Yumi Yasui; Taishi Yonetsu; Tetsuo Sasano; Tsunekazu Kakuta
Journal:  PLoS One       Date:  2021-08-13       Impact factor: 3.240

4.  Obstructive sleep apnea is associated with coronary microvascular dysfunction: A systematic review from a clinical perspective.

Authors:  Rui-Heng Zhang; Wei Zhao; Lin-Ping Shu; Nan Wang; Yao-Hua Cai; Jin-Kui Yang; Jian-Bo Zhou; Lu Qi
Journal:  J Sleep Res       Date:  2020-04-15       Impact factor: 3.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.